GlycoNet Investigators study the sugars on red blood cells to find ways to make universal donor blood
48Hour Discovery shows exceptional innovation, growth, management, and societal impact, according to BestStartup.
The collaborative project is partnered with CQDM, Simon Fraser University, Amgen, Merck, and Servier.
A GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease
Scientific collaboration yields new hope for children affected by rare blood disorder
Linkedin-in Twitter Facebook-f Instagram Youtube Envelope About About GlycoNet Administration Corporate Policies Governance Board of Directors Executive Committee Finance & Audit Committee Nominating Committee Research Management Committee Scientific Advisory Board Commercialization & Legacy Committee Equity, Diversity and Inclusion Committee Training Committee Partners Become a Member Research Research Themes Introduction to Glycomics Call for Proposals Core […]
Dr. Yves St-Pierre shared how glycomics could help develop a new-generation cancer immunotherapy.
Trainees will receive support and resources while advancing glycomics research in areas such as antimicrobials, drug discovery, immune response, cancer, and neurodegenerative diseases
Linkedin-in Twitter Facebook-f Instagram Youtube Envelope
From offering policy advice to sharing his expertise on COVID-19 with the media and public, Dr. Donald Sheppard is recognized a role model with his achievement in engaging with the broader community